These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 38382244

  • 1. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder.
    Goldman-Yassen A, Lee A, Gombolay G.
    Pediatr Neurol; 2024 Apr; 153():125-130. PubMed ID: 38382244
    [Abstract] [Full Text] [Related]

  • 2. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis.
    Molazadeh N, Akaishi T, Bose G, Nishiyama S, Chitnis T, Levy M.
    Mult Scler Relat Disord; 2023 Dec; 80():105093. PubMed ID: 37949025
    [Abstract] [Full Text] [Related]

  • 3. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.
    Redenbaugh V, Chia NH, Cacciaguerra L, McCombe JA, Tillema JM, Chen JJ, Lopez Chiriboga AS, Sechi E, Hacohen Y, Pittock SJ, Flanagan EP.
    Mult Scler; 2023 Jun; 29(7):799-808. PubMed ID: 37218499
    [Abstract] [Full Text] [Related]

  • 4. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
    Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP.
    Neurology; 2023 Mar 28; 100(13):e1418-e1432. PubMed ID: 36690455
    [Abstract] [Full Text] [Related]

  • 5. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
    Camera V, Holm-Mercer L, Ali AAH, Messina S, Horvat T, Kuker W, Leite MI, Palace J.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2137833. PubMed ID: 34878547
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J.
    Mult Scler Relat Disord; 2021 Feb 01; 48():102718. PubMed ID: 33388560
    [Abstract] [Full Text] [Related]

  • 9. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
    Li EC, Zheng Y, Cai MT, Lai QL, Fang GL, Du BQ, Shen CH, Zhang YX, Wu LJ, Ding MP.
    Epilepsia; 2022 Sep 01; 63(9):2173-2191. PubMed ID: 35652436
    [Abstract] [Full Text] [Related]

  • 10. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
    Bauer A, Rudzki D, Berek K, Dinoto A, Lechner C, Wendel EM, Hegen H, Deisenhammer F, Berger T, Höftberger R, Rostasy K, Mariotto S, Reindl M.
    Front Immunol; 2022 Sep 01; 13():1037812. PubMed ID: 36451827
    [Abstract] [Full Text] [Related]

  • 11. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.
    Ciotti JR, Eby NS, Brier MR, Wu GF, Chahin S, Cross AH, Naismith RT.
    Mult Scler; 2022 Jan 01; 28(1):49-60. PubMed ID: 33870786
    [Abstract] [Full Text] [Related]

  • 12. Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder.
    Luo X, Li H, Xia W, Quan C, ZhangBao J, Tan H, Wang N, Bao Y, Geng D, Li Y, Yang L.
    Eur Radiol; 2024 Jul 01; 34(7):4364-4375. PubMed ID: 38127076
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of clinical and imaging data between patients with myelin oligodendrocyte glycoprotein antibody disease and patients with aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder.
    Xie H, Shao Y, Du J, Song Y, Li Y, Duan R, Yao Y, Gong Z, Teng J, Jia Y.
    J Neurol; 2022 Mar 01; 269(3):1641-1650. PubMed ID: 34383114
    [Abstract] [Full Text] [Related]

  • 14. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
    Cortese R, Prados Carrasco F, Tur C, Bianchi A, Brownlee W, De Angelis F, De La Paz I, Grussu F, Haider L, Jacob A, Kanber B, Magnollay L, Nicholas RS, Trip A, Yiannakas M, Toosy AT, Hacohen Y, Barkhof F, Ciccarelli O.
    Neurology; 2023 Jan 17; 100(3):e308-e323. PubMed ID: 36192175
    [Abstract] [Full Text] [Related]

  • 15. The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis.
    Tan YY, Saffari SE, Tye JSN, Peng X, Koh MJ, Mahmood ABSB, Tan JMM, Tan K, Yeo T.
    Mult Scler Relat Disord; 2024 Sep 17; 89():105775. PubMed ID: 39053396
    [Abstract] [Full Text] [Related]

  • 16. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S, Hashimoto B, Izaki S, Oji S, Fukaura H, Nomura K.
    Mult Scler Relat Disord; 2020 Jun 17; 41():102005. PubMed ID: 32114369
    [Abstract] [Full Text] [Related]

  • 17. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
    Messina S, Mariano R, Roca-Fernandez A, Cavey A, Jurynczyk M, Leite MI, Calabrese M, Jenkinson M, Palace J.
    Mult Scler; 2022 Feb 17; 28(2):217-227. PubMed ID: 34048323
    [Abstract] [Full Text] [Related]

  • 18. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease.
    Cacciaguerra L, Abdel-Mannan O, Champsas D, Mankad K, Krecke KN, Chen JJ, Syc-Mazurek SB, Redenbaugh V, Lopez-Chiriboga AS, Valencia-Sanchez C, Hemingway C, Tillema JM, Ciccarelli O, Pittock SJ, Hacohen Y, Flanagan EP.
    Neurology; 2024 May 28; 102(10):e209303. PubMed ID: 38710000
    [Abstract] [Full Text] [Related]

  • 19. Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics.
    Fujihara K, Cook LJ.
    Curr Opin Neurol; 2020 Jun 28; 33(3):300-308. PubMed ID: 32374571
    [Abstract] [Full Text] [Related]

  • 20. Serum Neurofilament Light and GFAP Are Associated With Disease Severity in Inflammatory Disorders With Aquaporin-4 or Myelin Oligodendrocyte Glycoprotein Antibodies.
    Chang X, Huang W, Wang L, ZhangBao J, Zhou L, Lu C, Wang M, Yu J, Li H, Li Y, Zhao C, Lu J, Quan C.
    Front Immunol; 2021 Jun 28; 12():647618. PubMed ID: 33796113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.